TABLE 2.
Dosage & Timing of Measurements | MABP (mm Hg) | HR (beats/min) | pH | PCO2 (mm Hg) | PO2 (mm Hg) |
---|---|---|---|---|---|
vehicle
| |||||
before 3-VO | 108.7 ± 4.5 | 348.6 ± 14.7 | 7.440 ± 0.024 | 31.3 ± 1.9 | 164.5 ± 3.0 |
during 3-VO & infusion | 107.0 ± 4.2 | 373.1 ± 19.1 | 7.436 ± 0.024 | 29.3 ± 1.8 | 176.4 ± 7.7 |
after infusion | 102.4 ± 2.9 | 377.3 ± 14.7 | 7.425 ± 0.016 | 30.1 ± 2.7 | 174.2 ± 8.3 |
| |||||
0.092 mg/kg TSC
| |||||
before 3-VO | 106.0 ± 3.2 | 368.6 ± 18.7 | 7.418 ± 0.020 | 32.9 ± 1.9 | 172.3 ± 7.5 |
during 3-VO & infusion | 106.1 ± 3.3 | 395.8 ± 17.3 | 7.417 ± 0.018 | 31.8 ± 1.7 | 184.1 ± 9.4 |
after infusion | 103.9 ± 3.3 | 391.4 ± 14.6 | 7.431 ± 0.014 | 31.4 ± 1.1 | 170.3 ± 15.9 |
Values shown are means ± SEs. No significant intergroup differences were observed for MABP, heart rate, blood pH, blood PCO2, or blood PO2.